We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Technology | 18.75% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
ICU Medical
ICUI
$4.16B
| $22.2M | 0.06% |
120,626
-48,553
| -29% | -$9.64M |
|
|
PAE
377
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $22M | 0.05% |
2,300,000
| – | – |
|
378
AutoZone
AZO
$51.3B
| $22M | 0.05% |
19,489
+2,438
| +14% | +$2.57M |
|
379
Howmet Aerospace
HWM
$109B
| $21.9M | 0.05% |
1,383,677
+1,363,730
| +6,837% | +$17.9M |
|
380
Magnachip Semiconductor
MX
$110M
| $21.8M | 0.05% |
2,115,000
+310,000
| +17% | +$3.45M |
|
381
Granite Construction
GVA
$5.16B
| $21.3M | 0.05% |
1,114,587
+664,233
| +147% | +$11.3M |
|
382
Sysco
SYY
$40.8B
| $21.2M | 0.05% |
387,269
-11,562
| -3% | -$608K |
|
|
PRAH
383
DELISTED
PRA Health Sciences, Inc.
PRAH
| $21.1M | 0.05% |
217,112
-34,484
| -14% | -$3.21M |
|
384
Kratos Defense & Security Solutions
KTOS
$8.23B
| $21M | 0.05% |
1,345,000
+549,756
| +69% | +$8.8M |
|
385
Lamar Advertising Co
LAMR
$16.7B
| $21M | 0.05% |
314,460
+26,194
| +9% | +$1.6M |
|
386
Phillips 66
PSX
$82.9B
| $20.9M | 0.05% |
290,251
+94,612
| +48% | +$6.7M |
|
|
STL
387
DELISTED
Sterling Bancorp
STL
| $20.4M | 0.05% |
1,740,514
+200,829
| +13% | +$2.3M |
|
388
Jacobs Solutions
J
$16B
| $20.3M | 0.05% |
+290,022
| New | +$19.6M |
|
389
Prologis
PLD
$136B
| $20.3M | 0.05% |
217,836
-204,230
| -48% | -$18.2M |
|
|
MRTX
390
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $20.3M | 0.05% |
177,950
+162,849
| +1,078% | +$15.8M |
|
391
SLB Ltd
SLB
$72.7B
| $20.1M | 0.05% |
1,093,337
-482,893
| -31% | -$8.46M |
|
392
Timken Company
TKR
$9.19B
| $20M | 0.05% |
440,692
-183,300
| -29% | -$7.24M |
|
393
Black Diamond Therapeutics
BDTX
$95.1M
| $20M | 0.05% |
474,727
+74,727
| +19% | +$2.75M |
|
394
S&P Global
SPGI
$124B
| $19.9M | 0.05% |
60,424
-15,998
| -21% | -$4.81M |
|
395
Medpace
MEDP
$16.3B
| $19.9M | 0.05% |
213,722
-74,992
| -26% | -$6.38M |
|
396
National Vision
EYE
$1.76B
| $19.8M | 0.05% |
650,000
+114,500
| +21% | +$3M |
|
397
Stoke Therapeutics
STOK
$1.84B
| $19.8M | 0.05% |
830,400
| – | – |
|
|
MIME
398
DELISTED
Mimecast Limited
MIME
| $19.7M | 0.05% |
473,791
| – | – |
|
|
ATXS
399
DELISTED
Astria Therapeutics
ATXS
| $19.6M | 0.05% |
507,967
| – | – |
|
400
White Mountains Insurance
WTM
$5.33B
| $19.4M | 0.05% |
21,810
-3,619
| -14% | -$3.26M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.